Below are the most recent publications written about "Pain Measurement" by people in Profiles.
-
Reilly ED, Grigorian HL, Heapy AA, Etingen B, Kelly MM, Wolkowicz NR, Girouard CM, Hogan TP, Bernice K, Bickmore T. Assessment of Two Online Interventions for Veterans With Chronic Pain: Protocol for a Randomized Controlled Efficacy Trial. JMIR Res Protoc. 2025 Aug 13; 14:e70601.
-
Goldfine CE, Wilson JM, Kaithamattam J, Hasdianda MA, Mancey K, Rehding A, Schreiber KL, Chai PR, Weiner SG. Randomized Trial of Self-Selected Music Intervention on Pain and Anxiety in Emergency Department Patients with Musculoskeletal Back Pain. West J Emerg Med. 2025 Jun 25; 26(4):1112-1119.
-
Curti F, Marsocci A, Massarelli D, Magnifica F. Assessment of erector spinal muscles activation in pre and post training with surface electromyography in an equestrian athlete with recurring non-specific low back pain: a case report. J Bodyw Mov Ther. 2025 Oct; 44:444-451.
-
Gong AJ, Choi R, Ring NY, Garg T, Mehta T, Weiss CR. Comparison of the Patient-Reported Outcome Measure for Vascular Malformation and Outcome Measures for Vascular Malformation Questionnaires: A Prospective Cohort Study. J Vasc Interv Radiol. 2025 08; 36(8):1347-1351.e6.
-
Tambiah J, Kennedy S, Swearingen C, McAlindon T, Yazici Y. Impact of structural severity on outcomes in knee osteoarthritis: an analysis of data from phase 2 and phase 3 lorecivivint clinical trials. Rheumatology (Oxford). 2025 May 01; 64(5):2583-2590.
-
Ayers DC, Zheng H, Yang W, Yousef M. The Chitranjan S. Ranawat Award: Factors That Predict Outcome Five Years Following Total Knee Arthroplasty. J Arthroplasty. 2025 Jul; 40(7S1):S12-S19.
-
Yazici Y, Tambiah JRS, Swearingen CJ, Lopez VA, Kennedy S, Fineman MS, Simsek I, Solomon E, Mcalindon TE. A Phase 3, 28-week, multicentre, randomised, double-blind, placebo-controlled trial (OA-10) to evaluate the efficacy and safety of a single injection of lorecivivint in the target knee joint of moderately to severely symptomatic osteoarthritis patients. Clin Exp Rheumatol. 2025 May; 43(5):847-853.
-
Yazici Y, Tambiah JRS, Swearingen CJ, Britt J, Kennedy S, Fineman MS, Simsek I, Solomon E, McAlindon TE. A Phase 3, 56-week, randomised, double-blind, placebo-controlled study (OA-11) utilising patient-reported and radiographic outcomes evaluating the efficacy and safety of a lorecivivint injection in patients with moderate to severe knee osteoarthritis. Clin Exp Rheumatol. 2025 May; 43(5):854-860.
-
Goldsmith A, Driver L, Duggan NM, Riscinti M, Martin D, Heffler M, Shokoohi H, Dreyfuss A, Sell J, Brown C, Fung C, Perice L, Bennett D, Truong N, Jafry SZ, Macias M, Brown J, Nagdev A. Complication Rates After Ultrasonography-Guided Nerve Blocks Performed in the Emergency Department. JAMA Netw Open. 2024 11 04; 7(11):e2444742.
-
Gerhart J, Burns JW, Thorn B, Jensen M, Carmody J, Keefe F. Treatment mechanism and outcome decoupling effects in cognitive therapy, mindfulness-based stress reduction, and behavior therapy for chronic pain. Pain. 2025 Feb 01; 166(2):408-419.